Your browser doesn't support javascript.
loading
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting.
Greenberg, Lauren; Ryom, Lene; Wandeler, Gilles; Grabmeier-Pfistershammer, Katharina; Öllinger, Angela; Neesgaard, Bastian; Stephan, Christoph; Calmy, Alexandra; Rauch, Andri; Castagna, Antonella; Spagnuolo, Vincenzo; Johnson, Margaret; Stingone, Christof; Mussini, Cristina; De Wit, Stéphane; Necsoi, Coca; Campins, Antoni A; Pradier, Christian; Stecher, Melanie; Wasmuth, Jan-Christian; Monforte, Antonella d'Arminio; Law, Matthew; Puhr, Rainer; Chkhartishvilli, Nikoloz; Tsertsvadze, Tengiz; Garges, Harmony; Thorpe, David; Lundgren, Jens D; Peters, Lars; Bansi-Matharu, Loveleen; Mocroft, Amanda.
Afiliación
  • Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
  • Ryom L; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Grabmeier-Pfistershammer K; Wiener Medizinische Universität, Vienna, Austria.
  • Öllinger A; Wiener Medizinische Universität, Vienna, Austria.
  • Neesgaard B; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Stephan C; Frankfurt HIV Cohort Study, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany.
  • Calmy A; Swiss HIV Cohort Study (SHCS), University of Zurich, Zurich, Switzerland.
  • Rauch A; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
  • Spagnuolo V; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
  • Johnson M; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.
  • Stingone C; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.
  • Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • De Wit S; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Necsoi C; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Campins AA; PISCIS Cohort Study, HIV Unit, Department of Internal Medicine, Hospital Son Espases de Mallorca, Spain.
  • Pradier C; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
  • Stecher M; University Hospital Cologne, Cologne, Germany.
  • Wasmuth JC; University Hospital Bonn, Bonn, Germany.
  • Monforte AD; Italian Cohort Naïve Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.
  • Law M; The Australian HIV Observational Database (AHOD), UNSW, Sydney, Australia.
  • Puhr R; The Australian HIV Observational Database (AHOD), UNSW, Sydney, Australia.
  • Chkhartishvilli N; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
  • Tsertsvadze T; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
  • Garges H; ViiV Healthcare, RTP, NC; and.
  • Thorpe D; Gilead science, Foster City, CA.
  • Lundgren JD; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Peters L; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bansi-Matharu L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
  • Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
J Acquir Immune Defic Syndr ; 83(3): 240-250, 2020 03 01.
Article en En | MEDLINE | ID: mdl-31923088
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de Integrasa / Fármacos Anti-VIH Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de Integrasa / Fármacos Anti-VIH Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido